Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin–Angiotensin System Inhibitors Therapy.
Saved in:
| Title: | Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin–Angiotensin System Inhibitors Therapy. |
|---|---|
| Authors: | Lin, Wei‐Ren1 (AUTHOR), Huang, Tzu‐Shan1 (AUTHOR), Chang, Ho‐Hsiang2 (AUTHOR), Chao, Jo‐Yen1 (AUTHOR), Chang, Yi‐Hsin3 (AUTHOR), Yang, Chen‐Yi3 (AUTHOR), Ou, Huang‐Tz3,4 (AUTHOR) huangtz@mail.ncku.edu.tw, Lin, Wei‐Hung1 (AUTHOR) dindonwhlin@hotmail.com |
| Source: | CTS: Clinical & Translational Science. Mar2026, Vol. 19 Issue 3, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17528054 |
|---|---|
| DOI: | 10.1111/cts.70509 |
